Clinical Trial Update: Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy [Phase 3]

View source ↗

Summary

This document covers a Phase 3 trial evaluating off-label bevacizumab (Avastin) for serosanguinous maculopathy. The study targets choroidal neovascularization a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Choroidal Neovascularisation, Polypoidal Choroidal Vasculopathy | Phase 3 | Status: UNKNOWN